Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2023 Filed Jun 23, 2023 16:31 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 57,754 | $9.05 | $522,673.70 |
DisclosureSEC source: 0000950170-23-029655 · ownership.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,868,228 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 16:30 UTC |
Qureshi Danish J.See Remarks
|
SaleCommon Stock | 587 | $9.07 | $5,324.09 |
DisclosureSEC source: 0000899243-23-016246 · doc4.xml · nonDerivative · entry 2 Qureshi Danish J. · CIK 0001864331 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,583,404 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 16:30 UTC |
Qureshi Danish J.See Remarks
|
SaleCommon Stock | 71,811 | $9.03 | $648,453.33 |
DisclosureSEC source: 0000899243-23-016246 · doc4.xml · nonDerivative · entry 1 Qureshi Danish J. · CIK 0001864331 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,583,991 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 17:24 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 45,984 | $8.95 | $411,556.80 |
DisclosureSEC source: 0000899243-23-015627 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,925,982 Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 16:31 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 47,142 | $8.71 | $410,606.82 |
DisclosureSEC source: 0000950170-23-027977 · ownership.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,971,966 Read SEC document |
| June 12, 2023 Filed Jun 13, 2023 17:47 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 2,858 | $8.51 | $24,321.58 |
DisclosureSEC source: 0000950170-23-027784 · ownership.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,019,108 Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 4,785 | $7.62 | $36,461.70 |
DisclosureSEC source: 0000899243-23-010866 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,021,966 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 21:00 UTC |
Pardo RyanSee Remarks
|
SaleCommon Stock | 6,398 | $7.62 | $48,752.76 |
DisclosureSEC source: 0000899243-23-010863 · doc4.xml · nonDerivative · entry 1 Pardo Ryan · CIK 0001865531 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,597 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:00 UTC |
Patel-Dunn AnishaChief Medical Officer
|
SaleCommon Stock | 7,319 | $7.62 | $55,770.78 |
DisclosureSEC source: 0000899243-23-010861 · doc4.xml · nonDerivative · entry 1 Patel-Dunn Anisha · CIK 0001864311 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,657 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:00 UTC |
Qureshi Danish J.See Remarks
|
SaleCommon Stock | 8,775 | $7.62 | $66,865.50 |
DisclosureSEC source: 0000899243-23-010862 · doc4.xml · nonDerivative · entry 1 Qureshi Danish J. · CIK 0001864331 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,655,802 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:10 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 69,734 | $7.61 | $530,675.74 |
DisclosureSEC source: 0000899243-23-010874 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,436,448 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.46 to $7.77 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:00 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 6,399 | $7.62 | $48,760.38 |
DisclosureSEC source: 0000899243-23-010864 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,506,182 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:00 UTC |
Pantaleoni PabloChief Medical Officer
|
SaleCommon Stock | 6,435 | $7.62 | $49,034.70 |
DisclosureSEC source: 0000899243-23-010865 · doc4.xml · nonDerivative · entry 1 Pantaleoni Pablo · CIK 0001864258 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,126,474 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:00 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 97,266 | $7.43 | $722,686.38 |
DisclosureSEC source: 0000899243-23-010555 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,512,581 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.17 to $7.53 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 16:30 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 43,705 | $6.14 | $268,348.70 |
DisclosureSEC source: 0000899243-23-008876 · doc4.xml · nonDerivative · entry 2 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,609,847 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.23 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 16:30 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 200 | $6.11 | $1,222.00 |
DisclosureSEC source: 0000899243-23-008876 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653,552 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 17:51 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 800 | $6.11 | $4,888.00 |
DisclosureSEC source: 0000899243-23-008603 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653,752 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 17:00 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 122,295 | $6.12 | $748,445.40 |
DisclosureSEC source: 0000899243-23-008136 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,654,552 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.22 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:18 UTC |
Pardo RyanSee Remarks
|
GrantCommon Stock | 192,307 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007557 · doc4.xml · nonDerivative · entry 1 Pardo Ryan · CIK 0001865531 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,995 F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:19 UTC |
Patel-Dunn AnishaChief Medical Officer
|
GrantCommon Stock | 192,307 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007558 · doc4.xml · nonDerivative · entry 1 Patel-Dunn Anisha · CIK 0001864311 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,976 F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:20 UTC |
Gouk WarrenChief Administrative Officer
|
GrantCommon Stock | 58,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007560 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,026,751 F1 · shares: Includes 58,760 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:22 UTC |
Qureshi Danish J.See Remarks
|
GrantCommon Stock | 320,512 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007566 · doc4.xml · nonDerivative · entry 1 Qureshi Danish J. · CIK 0001864331 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,664,577 F1 · shares: Includes 320,512 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:19 UTC |
Mullins Kevin MichaelChief Development Officer
|
GrantCommon Stock | 192,307 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007559 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,776,847 F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:23 UTC |
Pantaleoni PabloChief Digital Officer
|
GrantCommon Stock | 197,649 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007567 · doc4.xml · nonDerivative · entry 1 Pantaleoni Pablo · CIK 0001864258 · Chief Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132,909 F1 · shares: Includes 197,649 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:18 UTC |
Burdick Kenneth ADirector · Chief Executive Officer
|
GrantCommon Stock | 544,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007556 · doc4.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361,110 F2 · shares: Includes 544,871 RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:18 UTC |
Burdick Kenneth ADirector · Chief Executive Officer
|
GrantCommon Stock | 1,816,239 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007556 · doc4.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,816,239 F1 · shares: Includes 1,816,239 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:25 UTC |
Bourdon DavidChief Financial Officer
|
GrantCommon Stock | 160,256 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007568 · doc4.xml · nonDerivative · entry 1 Bourdon David · CIK 0001823690 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,016 F1 · shares: Includes 160,256 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:21 UTC |
Varanakis AnnChief People Officer
|
GrantCommon Stock | 96,153 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007563 · doc4.xml · nonDerivative · entry 1 Varanakis Ann · CIK 0001965703 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,102 F1 · shares: Includes 96,153 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 17:35 UTC |
Bourdon DavidChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,250,000 | $0.00 Strike: $5.53 | $0.00 |
DisclosureSEC source: 0000899243-22-035720 · doc4.xml · derivative · entry 3 Bourdon David · CIK 0001823690 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2032-11-10 F1 · shares: The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan. F2 · derivative.exercise_date: Includes an option to purchase 416,666 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Includes an option to purchase 833,334 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 17:35 UTC |
Bourdon DavidChief Financial Officer
|
Tax withholdingCommon Stock | 77,072 | $5.53 | $426,208.16 |
DisclosureSEC source: 0000899243-22-035720 · doc4.xml · nonDerivative · entry 2 Bourdon David · CIK 0001823690 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,760 Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 17:35 UTC |
Bourdon DavidChief Financial Officer
|
GrantCommon Stock | 180,832 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-035720 · doc4.xml · nonDerivative · entry 1 Bourdon David · CIK 0001823690 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,832 Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 07:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 15,106 | $7.20 | $108,763.20 |
DisclosureSEC source: 0000899243-22-035404 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967,991 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.13 to $7.29 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 16:35 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 15,106 | $7.49 | $113,143.94 |
DisclosureSEC source: 0000899243-22-034764 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,983,097 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.38 to $7.64 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 17:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 15,106 | $7.06 | $106,648.36 |
DisclosureSEC source: 0000899243-22-034278 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,998,203 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.11 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 16:30 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 15,106 | $8.01 | $120,999.06 |
DisclosureSEC source: 0000899243-22-033823 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,013,309 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.80 to $8.19 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 17:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 15,106 | $7.45 | $112,539.70 |
DisclosureSEC source: 0000899243-22-033401 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,028,415 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.26 to $7.70 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 17:45 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 15,106 | $7.02 | $106,044.12 |
DisclosureSEC source: 0000899243-22-033043 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,043,521 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.09 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 16:33 UTC |
Mullins Kevin MichaelChief Development Officer
|
SaleCommon Stock | 82,520 | $7.03 | $580,115.60 |
DisclosureSEC source: 0000899243-22-032431 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,584,540 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.20 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 19:10 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 51,672 | $9.01 | $465,564.72 |
DisclosureSEC source: 0000899243-22-030753 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,058,627 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $9.00 to $9.07 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 19:11 UTC |
Qureshi Danish J.See Remarks
|
GrantStock Option (right to buy) · Derivative | 2,821,362 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0000899243-22-030755 · doc4.xml · derivative · entry 1 Qureshi Danish J. · CIK 0001864331 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,821,362 Underlying: Common Stock · 2,821,362 shares Expires 2032-09-07 F1 · shares: The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan. F2 · derivative.exercise_date: Includes an option to purchase 940,454 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Includes an option to purchase 1,880,908 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 23:11 UTC |
Burdick Kenneth ADirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 9,404,539 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0000899243-22-030756 · doc4.xml · derivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,404,539 Underlying: Common Stock · 9,404,539 shares Expires 2032-09-07 F1 · shares: The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan. F2 · derivative.exercise_date: Includes an option to purchase 3,134,846 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Includes an option to purchase 6,269,693 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 17:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 34,449 | $7.00 | $241,143.00 |
DisclosureSEC source: 0000899243-22-030682 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,110,299 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 23, 2022 Filed Aug 24, 2022 17:15 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 17,226 | $7.02 | $120,926.52 |
DisclosureSEC source: 0000899243-22-029613 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,144,748 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.11 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 17,226 | $7.85 | $135,224.10 |
DisclosureSEC source: 0000899243-22-028779 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,161,974 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.66 to $8.10 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 17:00 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 17,226 | $7.30 | $125,749.80 |
DisclosureSEC source: 0000899243-22-028262 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,179,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.20 to $7.42 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 16:15 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 68,904 | $7.00 | $482,328.00 |
DisclosureSEC source: 0000899243-22-027829 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,196,426 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at in each transaction for $7.00. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 16:40 UTC |
Gouk WarrenChief Administrative Officer
|
SaleCommon Stock | 67,479 | $5.32 | $358,988.28 |
DisclosureSEC source: 0000899243-22-022392 · doc4.xml · nonDerivative · entry 1 Gouk Warren · CIK 0001865503 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,275,330 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 20:44 UTC |
Pardo RyanSee Remarks
|
SaleCommon Stock | 56,370 | $5.35 | $301,579.50 |
DisclosureSEC source: 0000899243-22-022402 · doc4.xml · nonDerivative · entry 1 Pardo Ryan · CIK 0001865531 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,688 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 16:41 UTC |
Gorcyca FeliciaChief People Officer
|
SaleCommon Stock | 2,638 | $5.33 | $14,060.54 |
DisclosureSEC source: 0000899243-22-022394 · doc4.xml · nonDerivative · entry 1 Gorcyca Felicia · CIK 0001865529 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 909,582 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 16:42 UTC |
Booth Gwen H.Chief Operating Officer
|
SaleCommon Stock | 88,798 | $5.27 | $467,965.46 |
DisclosureSEC source: 0000899243-22-022395 · doc4.xml · nonDerivative · entry 1 Booth Gwen H. · CIK 0001864862 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,083,637 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.